Clinical trial
Evaluating the Safety and Efficacy of the AquaPass System a Renal-independent Fluid Removal System in ADHF Patients Suffering From Fluid Overload. a European Registry
NCT06401109 is registered in ClinicalTrials.gov with AquaPass Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Safety and Efficacy of the AquaPass System a Renal-independent Fluid Removal System in ADHF Patients Suffering From Fluid Overload. a European Registry
- Lead sponsor
- AquaPass Medical Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2025
- Completion date
- May 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute decompensated heart failure, chronic heart failure, edema, fluid overload